![Aron Feingold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Aron Feingold formerly worked at Sangamo Therapeutics, Inc., as Head-Media & Investor Relations from 2018 to 2022 and Geron Corp., as Head-Investor & Media Relations from 2022 to 2025.
Former positions of Aron Feingold
| Companies | Position | End |
|---|---|---|
| GERON CORPORATION | Investor Relations Contact | 31/05/2025 |
| SANGAMO THERAPEUTICS, INC. | Investor Relations Contact | 28/02/2022 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
- Stock Market
- Insiders
- Aron Feingold
